Global Preclinical CRO Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Preclinical CRO Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The preclinical cro market size has experienced robust expansion in recent years. It is projected to grow from $5.7 billion in 2024 to $6.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.7%. This historic growth is primarily attributed to the increasing demand for faster drug development, the implementation of cost containment strategies, a strategic focus on core competencies, stringent regulatory compliance requirements, and the globalization of clinical trials.

The preclinical cro market is projected to experience substantial expansion over the upcoming years, with its size anticipated to reach $8.99 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. This growth within the forecast period can be attributed to several factors, including the rise of personalized medicine, a concentrated focus on rare diseases and orphan drugs, greater outsourcing activities within biopharmaceuticals, a stronger emphasis on biomarker research, and the increasing demand for real-world evidence generation. Key trends expected within the forecast period encompass the integration of artificial intelligence (AI), the broadening of oncology research, progress in omics technologies, the development of advanced in vitro and in vivo models, and enhanced collaboration for translational research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp

What Are The Drivers Pushing New Developments In The Preclinical CRO Market?

The anticipated expansion of the preclinical CRO market going forward is directly tied to the rising need for preclinical trials. These trials involve any study performed on medicines or treatments for conditions before they are tested on human volunteers. Preclinical investigations frequently involve new medical devices, prescription drugs, and diagnostic tools, with their main goals being to establish a preliminary safe dose for first-in-human studies and to evaluate the product’s potential toxicity. Preclinical trials are crucial in drug development, and their significance is growing due to the heightened emphasis on the safety and effectiveness of new medications. As an illustration, in February 2024, IQVIA, a US-based company serving the combined industries of health information technology and clinical research, reported an increase in clinical development productivity during 2023, where a total of 69 novel active substances (NASs) were launched globally in 2023, representing 6 more than the prior year, and including 24 first-in-class launches in the U.S. Therefore, the increasing demand for preclinical trials is propelling the growth of the preclinical CRO market going forward.

What Are The Key Segments In The Preclinical CRO Market?

The preclinical cromarket covered in this report is segmented –

1) By Service: Bioanalysis And DMPK Studies; Toxicology Testing; Compound Management; Chemistry; Safety Pharmacology; Others Services

2) By Type: Patient Derived Organoid (PDO) Model; Patient Derived Xenograft Model

3) By Animal Model: Small Animal Model; Large Animal Model

4) By Model System: In Vivo; In Vitro

5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device Companies; Other End-users

Subsegments:

1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies; Pharmacodynamics Studies; Drug Metabolism Studies

2) By Toxicology Testing: Acute Toxicity Testing; Chronic Toxicity Testing; Reproductive Toxicity Testing

3) By Compound Management: Sample Management; Inventory Management; Formulation Services

4) By Chemistry: Medicinal Chemistry; Analytical Chemistry; Synthetic Chemistry

5) By Safety Pharmacology: Cardiovascular Safety Studies; Central Nervous System Safety Studies; Respiratory Safety Studies

6) By Other Services: Regulatory Consulting; Project Management; Data Management Services

Which Market Trends Are Creating New Opportunities In The Preclinical CRO Industry?

Technological advancements are emerging as a significant trend within the preclinical CRO market. Leading companies operating in this market are incorporating new technologies to secure their market standing. For instance, in February 2023, BenchSci, a Canadian AI solutions company focused on preclinical R&D, introduced ASCEND, an end-to-end SaaS platform designed for preclinical drug discovery. This platform aims to accelerate preclinical phase drug development pipelines by acquiring biological insights into the foundational mechanisms of disease. ASCEND utilizes BenchSci’s machine-learning technology to extract experimental data from both secure internal and public external sources. The platform then compares these experimental results against curated ontology datasets. Consequently, the software can generate an evidence-based map illustrating the biological processes that underpin various diseases.

Which Leading Players Are Enhancing Their Preclinical CRO Market Presence Worldwide?

Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

How Is Preclinical CRO Market Demand Varying Across Different Regions?

North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Preclinical CRO Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp

Browse Through More Reports Similar to the Global Preclinical CRO Market 2025, By The Business Research Company

Streaming Analytics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/streaming-analytics-global-market-report

Content Streaming Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/content-streaming-global-market-report

Ott Streaming Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ott-streaming-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795